Buyou Chen

677 total citations
23 papers, 523 citations indexed

About

Buyou Chen is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Buyou Chen has authored 23 papers receiving a total of 523 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 9 papers in Oncology and 5 papers in Cancer Research. Recurrent topics in Buyou Chen's work include RNA modifications and cancer (8 papers), Cancer-related gene regulation (6 papers) and Ubiquitin and proteasome pathways (4 papers). Buyou Chen is often cited by papers focused on RNA modifications and cancer (8 papers), Cancer-related gene regulation (6 papers) and Ubiquitin and proteasome pathways (4 papers). Buyou Chen collaborates with scholars based in China. Buyou Chen's co-authors include Runzhou Ni, Wenkai Ni, Cuihua Lu, Mingbing Xiao, Qun Xue, Guoxin Mao, Feng Jiang, Liting Lv, Tingting Ni and Xiaoyan Li and has published in prestigious journals such as Cancer Letters, Journal of Cellular Biochemistry and Digestive Diseases and Sciences.

In The Last Decade

Buyou Chen

23 papers receiving 521 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Buyou Chen China 16 386 149 109 100 57 23 523
Jörg Weimer Germany 15 410 1.1× 143 1.0× 149 1.4× 87 0.9× 64 1.1× 54 726
Minghui Zhang China 12 321 0.8× 173 1.2× 132 1.2× 61 0.6× 50 0.9× 19 494
Emmanuel Tubacher France 8 465 1.2× 170 1.1× 95 0.9× 73 0.7× 49 0.9× 11 708
Anke Van den broeck Belgium 6 233 0.6× 128 0.9× 285 2.6× 53 0.5× 46 0.8× 9 433
Timothy Ming-Hun Wan Hong Kong 12 296 0.8× 224 1.5× 192 1.8× 32 0.3× 46 0.8× 16 511
Jiabo Di China 15 286 0.7× 168 1.1× 237 2.2× 70 0.7× 132 2.3× 39 578
María Giselle Peters Argentina 10 300 0.8× 89 0.6× 177 1.6× 43 0.4× 51 0.9× 17 469
Chuanhe Yang United States 12 344 0.9× 221 1.5× 222 2.0× 183 1.8× 17 0.3× 15 593
Peter Lichter Germany 15 536 1.4× 151 1.0× 164 1.5× 61 0.6× 39 0.7× 17 781
Anna Wiles New Zealand 13 266 0.7× 76 0.5× 130 1.2× 42 0.4× 43 0.8× 17 437

Countries citing papers authored by Buyou Chen

Since Specialization
Citations

This map shows the geographic impact of Buyou Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Buyou Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Buyou Chen more than expected).

Fields of papers citing papers by Buyou Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Buyou Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Buyou Chen. The network helps show where Buyou Chen may publish in the future.

Co-authorship network of co-authors of Buyou Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Buyou Chen. A scholar is included among the top collaborators of Buyou Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Buyou Chen. Buyou Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yao, Ninghua, Shu Zhang, Song Yao, et al.. (2020). Identification of critical radioresistance genes in esophageal squamous cell carcinoma by whole-exome sequencing. Annals of Translational Medicine. 8(16). 998–998. 6 indexed citations
2.
Zhang, Xiubing, Pan Xu, Wenkai Ni, et al.. (2016). Downregulated DYRK2 expression is associated with poor prognosis and Oxaliplatin resistance in hepatocellular carcinoma. Pathology - Research and Practice. 212(3). 162–170. 31 indexed citations
3.
Zhang, Xiubing, Hua Lu, Fengbo Zhao, et al.. (2016). Overexpression of PCBP2 contributes to poor prognosis and enhanced cell growth in human hepatocellular carcinoma. Oncology Reports. 36(6). 3456–3464. 36 indexed citations
4.
Lu, Hua, Baoying Hu, Jinxia Liu, et al.. (2016). Upregulated expression of Nucleostemin/GNL3 is associated with poor prognosis and Sorafenib Resistance in Hepatocellular Carcinoma. Pathology - Research and Practice. 213(6). 688–697. 11 indexed citations
5.
Hu, Baoying, Hua Lu, Wenkai Ni, et al.. (2016). Nucleostemin/GNL3 promotes nucleolar polyubiquitylation of p27kip1 to drive hepatocellular carcinoma progression. Cancer Letters. 388. 220–229. 15 indexed citations
6.
Ni, Tingting, Guoxin Mao, Qun Xue, et al.. (2015). Upregulated expression of ILF2 in non-small cell lung cancer is associated with tumor cell proliferation and poor prognosis. Journal of Molecular Histology. 46(4-5). 325–335. 34 indexed citations
7.
Xu, Pan, Xiubing Zhang, Wenkai Ni, et al.. (2015). Upregulated HOXC8 Expression Is Associated with Poor Prognosis and Oxaliplatin Resistance in Hepatocellular Carcinoma. Digestive Diseases and Sciences. 60(11). 3351–3363. 24 indexed citations
8.
Liu, Yifei, Tingting Ni, Qun Xue, et al.. (2014). Involvement of p29/SYF2/fSAP29/NTC31 in the progression of NSCLC via modulating cell proliferation. Pathology - Research and Practice. 211(1). 36–42. 10 indexed citations
9.
Ji, Lili, Tingting Ni, Qun Xue, et al.. (2014). Transformer 2β (Tra2β/SFRS10) positively regulates the progression of NSCLC via promoting cell proliferation. Journal of Molecular Histology. 45(5). 573–582. 19 indexed citations
10.
Mao, Guoxin, Liting Lv, Buyou Chen, et al.. (2014). The expression levels and prognostic value of high temperature required A2 (HtrA2) in NSCLC. Pathology - Research and Practice. 210(12). 939–943. 12 indexed citations
11.
Ni, Wenkai, Buyou Chen, Cuihua Lu, et al.. (2013). Overexpressed nuclear BAG‐1 in human hepatocellular carcinoma is associated with poor prognosis and resistance to doxorubicin. Journal of Cellular Biochemistry. 114(9). 2120–2130. 19 indexed citations
12.
Ni, Runzhou, Qingchun Deng, Xiaodong Huang, et al.. (2013). Glyoxylate Reductase/Hydroxypyruvate Reductase: A Novel Prognostic Marker for Hepatocellular Carcinoma Patients after Curative Resection. Pathobiology. 80(3). 155–162. 8 indexed citations
13.
Xiao, Mingbing, Runzhou Ni, Wenkai Ni, et al.. (2013). Serum GP73 is complementary to AFP and GGT-II for the diagnosis of hepatocellular carcinoma. Oncology Letters. 6(4). 1152–1158. 28 indexed citations
14.
Lv, Liting, Qun Xue, Chunhua Wan, et al.. (2013). Vacuolar protein sorting 4B, an ATPase protein positively regulates the progression of NSCLC via promoting cell division. Molecular and Cellular Biochemistry. 381(1-2). 163–171. 26 indexed citations
15.
Xue, Qun, Liting Lv, Chunhua Wan, et al.. (2013). Expression and clinical role of small glutamine-rich tetratricopeptide repeat (TPR)-containing protein alpha (SGTA) as a novel cell cycle protein in NSCLC. Journal of Cancer Research and Clinical Oncology. 139(9). 1539–1549. 16 indexed citations
16.
Xue, Qun, Yiqun Zhou, Chunhua Wan, et al.. (2013). Epithelial membrane protein 3 is frequently shown as promoter methylation and functions as a tumor suppressor gene in non-small cell lung cancer. Experimental and Molecular Pathology. 95(3). 313–318. 30 indexed citations
17.
Lv, Liting, Chunhua Wan, Buyou Chen, et al.. (2013). Nemo‐Like Kinase (NLK) Inhibits the Progression of NSCLC via Negatively Modulating WNT Signaling Pathway. Journal of Cellular Biochemistry. 115(1). 81–92. 36 indexed citations
18.
Xie, Ling, Wenkai Ni, Mingbing Xiao, et al.. (2012). The expressions and clinical significances of tissue and serum galectin-3 in pancreatic carcinoma. Journal of Cancer Research and Clinical Oncology. 138(6). 1035–1043. 61 indexed citations
19.
Shi, Hui, Huijie Wang, Jian‐Guo Zhang, et al.. (2012). CtBP2 contributes to malignant development of human esophageal squamous cell carcinoma by regulation of p16INK4A. Journal of Cellular Biochemistry. 114(6). 1343–1354. 29 indexed citations
20.
Xiao, Mingbing, Feng Jiang, Wenkai Ni, et al.. (2011). High expression of S100A11 in pancreatic adenocarcinoma is an unfavorable prognostic marker. Medical Oncology. 29(3). 1886–1891. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jörg Weimer Breakdown of academic impact, for papers by Minghui Zhang Breakdown of academic impact, for papers by Emmanuel Tubacher Breakdown of academic impact, for papers by Anke Van den broeck Breakdown of academic impact, for papers by Timothy Ming-Hun Wan Breakdown of academic impact, for papers by Jiabo Di Breakdown of academic impact, for papers by María Giselle Peters Breakdown of academic impact, for papers by Chuanhe Yang Breakdown of academic impact, for papers by Peter Lichter Breakdown of academic impact, for papers by Anna Wiles
Rankless by CCL
2026